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Abstract
Background: The study aimed at presenting normative data for both parallel forms of the “Rasch-based
Depression Screening (DESC)”, to examine its Rasch model conformity and convergent and divergent validity based
on a representative sample of the German general population.
Methods: The sample was selected with the assistance of a demographic consulting company applying a face to
face interview (N = 2509; mean age = 49.4, SD = 18.2; 55.8% women). Adherence to Rasch model assumptions was
determined with analysis of Rasch model fit (infit and outfit), unidimensionality, local independence (principal
component factor analysis of the residuals, PCFAR) and differential item functioning (DIF) with regard to
participants’ age and gender. Norm values were calculated. Convergent and divergent validity was determined
through intercorrelations with the depression and anxiety subscales of the Hospital Anxiety and Depression Scale
(HADS-D and HADS-A).
Results: Fit statistics were below critical values (< 1.3). There were no signs of DIF. The PCFAR revealed that the
Rasch dimension “depression” explained 68.5% (DESC-I) and 69.3% (DESC-II) of the variance, respectively which
suggests unidimensionality and local independence of the DESC. Correlations with HADS-D were rDESC-I = .61 and
rDESC-II = .60, whereas correlations with HADS-A were rDESC-I = .62 and rDESC-II = .60.
Conclusions: This study provided further support for the psychometric quality of the DESC. Both forms of the
DESC adhered to Rasch model assumptions and showed intercorrelations with HADS subscales that are in line with
the literature. The presented normative data offer important advancements for the interpretation of the
questionnaire scores and enhance its usefulness for clinical and research applications.
Background
Screening for depression is an important diagnostic task
in many clinical settings. Several established screening
instruments are available for this purpose like the Beck
Depression Inventory [BDI; 1], the Patient Health Ques-
tionnaire 9 [PHQ-9; 2], or the Hospital Anxiety and
Depression Scale [HADS; 3,4]. Most of the established
instruments were originally developed on the basis of
classical test theory (CTT) and many studies reported
excellent reliability and validity for these instruments
when relying upon CTT assumptions [e.g., 5,6].
However, in the last years it was demonstrated that
diagnostic instruments could benefit substantially from
modern statistical approaches like models of item
response theory (IRT), e.g., the Rasch model. The Rasch
model is one of the IRT models that holds some parti-
cularly beneficial attributes, e.g., interval scale level of
model parameters, sample free test calibration, and item
free person measurement [for an introduction to Rasch
analysis, see 7,8]. Applying IRT techniques, a slightly
more differentiated picture of the psychometric proper-
ties of the established screening instruments for depres-
sion emerged. For instance, by using IRT modeling it
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of test theory - cannot be taken for granted for some
instruments [9,10]. Furthermore it was shown that
instruments containing items related to somatic symp-
toms could lead to severe problems when assessing
patients with comorbid somatic diseases. If patients suf-
fering from a severe somatic illness reported somatic
symptoms in a depression questionnaire those symp-
toms may be ascribed to the somatic ailment or a
depressive episode [11-13]. This may lead to artificially
increased depression scores. Moreover, using IRT meth-
ods it was shown that established questionnaires could
be shortened without loss of information [14]. Generally,
in many studies applying IRT techniques, sound psycho-
metric characteristics of a depression screening instru-
ment could only be found if at least some items were
removed from the scale. The question, which items had
to be removed largely depended on the sample investi-
gated [e.g., 13,15-17]. However, sample dependent psy-
chometric characteristics of screening instruments may
aggravate the comparison of results across different
samples or studies.
The Rasch-based Depression Screening (DESC) is one
of the first instruments that were originally developed
using Rasch analysis. Its development was motivated by
two aspects. First, given the evidence for sample-depen-
dency of psychometric characteristics of many screening
instruments for depression when applying IRT model-
ing, the first aim was to use Rasch analysis to originally
develop a new instrument with stable psychometric
characteristics across a diversity of different clinical and
non-clinical samples. Second, as prior studies have
shown that using questionnaires of mood repeatedly at
short intervals produces artificial alteration of sum
scores [18,19] an instrument that provides two parallel
forms was lacking. Parallel forms are beneficial for retest
applications in longitudinal designs, e.g., monitoring
symptom change across treatment.
The DESC has already been shown to fit the Rasch
model in various patient samples, e.g., cardiologic, otor-
hinolaryngologic, neurologic patients or patients with
mental illnesses [20,21]. So, research up to now suggests
that the DESC is a psychometrically sound and concise
screening instrument consisting of two parallel forms
which measures depression severity across a broad
range of depression severity with high test accuracy.
However, despite the development of the DESC is in
an advanced stage, population based norms are lacking
to date. Population based norms for the DESC would
enhance easiness and reliability of diagnostic decisions
based on the DESC sum score on a single case basis. It
would provide important advancements for the interpre-
tation of the questionnaire scores and enhance its use-
fulness for clinical and research applications.
The primary aim of the current study was therefore to
collect normative data for both forms of the DESC based
on a representative sample of the German general popu-
lation. Prior to determination of norm values, Rasch
model conformity of the DESC in this sample was exam-
ined. Furthermore, convergent and divergent validity of
the DESC with regard to the anxiety and the depression
subscale of the Hospital Anxiety and Depression Scale
[HADS; 4,22] were determined. Possible applications of
the presented normative data are discussed.
Methods
Sample
A representative sample of the German general popula-
tion was selected with the assistance of a demographic
consulting company (USUMA, Berlin, Germany). The
area of Germany was divided into 258 sample areas
representing the different regions of the country. In
each sample area households were selected by using a
random route procedure with start addresses. Beginning
at the start address in an area, each 3
rd household was
contacted in order to conduct a face to face interview.
The sample was intended to be representative in terms
of age, gender and education. Inclusion criteria were age
at or above 14 years and German language skills (read
and understand). Between May and July 2009, a total of
4,572 households (valid addresses only) were approached
of which 2,524 agreed to participate (55.2%). If not at
home a maximum of four attempts were made to con-
tact the selected person. Twelve interviews were
removed from the dataset because of incomplete ques-
tionnaires; demographic information of three persons
was missing. Thus, the final study sample consisted of
2,509 persons. Mean age was 49.4 (SD = 18.2) with a
range from 14 to 94 years. The majority (55.8%) were
women. Sociodemographic characteristics of the sample
are presented in table 1.
All participants were visited by an interview assistant
and informed about the investigation. The interview
was based on a structured questionnaire that was filled
in by the respondents. An interview assistant waited
until the participant completed all questions and offered
help if participants did not understand the meaning of
the questions or the use of the response scale. The
study procedures were in accordance with the declara-
tion of Helsinki and approved by the local ethics
committee.
Material
DESC. The Rasch-based Depression Screening [DESC;
20] was developed on the basis of a calibrated Rasch-
homogeneous item bank [see 23 for details on the con-
struction process]. For the development of the DESC,
items of the item bank were selected if they showed an
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items should capture a broad range of depression sever-
ity similar to the range covered by the whole item bank.
Structural equation modelling was applied to evaluate
equivalence of the two scales [20]. Using Receiver Oper-
ating Characteristics (ROC) curves analysis the optimal
cut-off score of both DESC forms was determined to be
≥12 with regard to interview-based diagnosis of a
depressive disorder according to ICD-10 [24]. This cut-
off score proved to be sensitive and specific. The DESC
was developed to assess depression in both patients with
mental and somatic illnesses. In the initial development
it was found that no items on somatic symptoms could
be included to the instrument because these items did
not fit the model and violated the unidimensionality
assumption of the scale [20].
The DESC consists of two parallel versions with 10
items each. Items refer to the last two weeks, and parti-
cipants are asked to mark how often they experienced
each symptom on a 5-point Likert scale from 0 (never)
to 4 (always). An example of a DESC item is “how often
during the last two weeks did you feel sad?” (See table 2
for abbreviations of all DESC items). Total scores range
from 0 to 40 with higher scores indicating greater
depression. Participants completed both forms of the
DESC. The DESC is available from the principal author.
HADS. The Hospital Anxiety and Depression Scale
[HADS; 3,4,25] refers to the last week and consists of 14
items which are Likert scaled from 0 to 3 with changing
polarity. Seven items each constitute the anxiety and the
depression subscales. A cut off score of ≥ 8 is recom-
mended to identify persons suffering from a depressive
disorder according to ICD-10 [26]. The HADS was used
to calculate measures of convergent and divergent validity
of the DESC. The HADS was chosen to validate the DESC
because it was originally developed for depression screen-
ing in patients with somatic diseases, which is also one the
main fields of application for the DESC. Furthermore, it
provides screening information on depression and anxiety
symptoms, so that both convergent and divergent validity
could be examined simultaneously.
Table 1 Sample details
Total
N = 2509
Male
44.2% (N = 1109)
Female
55.8% (N = 1400)
age M 49.4 48.8 50.0
SD 18.2 18.1 18.4
Urbanity Rural area 14.5% (363) 14.5% (203) 14.5% (160)
Urban area 85.5 (2139) 85.5% (1195) 85.5 (944)
Education No qualifications 1.8% (44) 2.5% (35) 0.8% (9)
< 10 years 42.3% (1059) 42.5% (594) 42.1% (465)
10 years of education 35.9% (898) 38.3% (536) 32.8% (362)
> 10 years 16.8% (420) 14.3% (200) 19.9% (220)
Net household income < 1250€/month 24.1% (603) 27.0% (377) 20.5% (226)
1251 to 2500€/month 50.4% (1262) 48.9% (684) 52.4% (578)
≥ 2500€/month 22.7% (567) 21.2% (296) 24.5% (271)
Table 2 Item characteristics of the Rasch-based
Depression Screening I (DESC-I) and the Rasch-based
Depression Screening II (DESC-II)
Item δi * S.E. infit Outfit
Threshold < 1.30 < 1.30
DESC-I
sad -.85 .04 .93 1.01
lonely -.62 .05 .78 .75
despaired -.44 .04 .71 .65
hopeless -.31 .05 .67 .65
empty -.08 .05 .74 .84
loss of joy .24 .05 .60 .57
feel superfluous .31 .05 .67 .61
life is a burden .53 .06 .75 .76
life is a failure .68 .06 .66 .49
suicide 1.28 .09 .85 .67
DESC-II
disheartened -.80 .04 .86 .88
little pleasure -.66 .04 .83 .85
withdrawal -.33 .04 .92 .93
discouraged -.25 .04 .68 .66
uninspired -.03 .04 1.02 1.13
pessimistic .20 .05 .65 .68
feel needless .30 .05 .97 1.09
be no good .60 .06 .67 .62
loss of interest .89 .06 .86 .87
suicide 1.05 .08 .83 .52
Note: Measures δi were anchored on the original calibration sample reported
in Forkmann et al. [20]; S.E.: Standard Error
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graphic data sheet.
Data analysis
Data analysis was conducted in two steps. In the first
step, it was examined whether the Rasch model holds in
the representative German general population sample.
In the second step, based on these data norm values
and measures of convergent and divergent validity were
determined.
Step 1: Rasch analysis
The Rasch model conceptualizes the probability that a
person will endorse an item as a logistic function of the
difference between the person’s level of, in this case,
depression (θ, also referred to as the latent trait score or
person measure) and the level of depression expressed
by the item (δi) [27]. Because the Rasch model was ori-
ginally developed for intelligence and attainment tests, δi
is also often referred to as “item difficulty” [27]. For self-
report instruments, this term can be “translated” as
probability expressed in logits to endorse a high cate-
gory of an item. For “difficult” items this probability
would be lower than for “easy” items, relative to the
individual person measure. In this step, all analyses were
performed applying an extension of the Rasch Model,
the Partial Credit Model [PCM; 28]. The PCM allows
response categories to vary across items. This model
was chosen because it was shown to be more appropri-
ate to use the PCM than the competing Rating Scale
Model in the original development of the DESC [20].
To ensure comparability of the results presented here
with the original development sample of the DESC, item
difficulty estimates δi and thresholds were anchored on
the original calibration sample reported in Forkmann et
al. [20].
Separation and reliability
The item and person separation indices estimate the
spread or separation of persons and items on the mea-
sured variable relative to measurement error. Items
must be sufficiently well separated in terms of item diffi-
culty in order to identify the direction and meaning of
the latent scale [29]. A clinically useful set of items
should define at least three strata of patients and items
(e.g., high, moderate, and low levels of symptom bur-
den), which are reflected in a separation index of 2.0
and an associated separation reliability of. 80 [8,29].
Rasch model fit
Infit and outfit are mean square residual statistics of
model fit discrepancy with an expectation of 1.0 and a
range from 0 to infinity. Infit and outfit statistics reflect
slightly different approaches to assessing the fit of an
item: The infit statistic gives relatively more weight to
the answers of those persons closer to the item measure,
whereas the outfit statistic is not weighted and therefore
more sensitive to the influence of “outlying”,i . e .m o r e
extreme responses. Values ≤ 1.3 indicate good fit [7].
Unidimensionality and local independence
Unidimensionality and local independence are two impor-
tant interrelated assumptions of Item Response Theory.
Unidimensionality means that only one single latent
dimension (e.g., depression) accounts for the common var-
iance in the data. Evidence of essential unidimensionality
provides support for the assumption of local independence
because if all items measure the same underlying con-
struct, this construct accounts for any relationships among
items, and other relationships among items are unlikely
[30]. Thus, local independence means that when control-
ling for the major latent dimension no substantial inter-
correlations between the items shall remain. A principal
component factor analysis of the residuals (PCFAR) was
performed [31,32]. Since uni f o r mc r i t e r i ah a v ey e tt ob e
established for when a potential additional dimension
w o u l dh a v et ob ec o n s i d e r e d ,r e s u l t sw e r ei n t e r p r e t e d
according to the recommendations of Linacre [33]: > 60%
of variance explained by the Rasch dimension and ≤ 5%
explained by the greatest potential additional dimension
was considered as good. Additionally, an eigenvalue ≤ 3
indicates that the potential second dimension has only
marginal explanatory power. This result allows for ignor-
ing further components [33].
Evaluation of Differential Item Functioning (DIF)
Differential item functioning (DIF) investigates the items
in an instrument for signs of interactions with sample
characteristics. DIF analyses were performed for gender
and age for three reasons: Firstly, many studies showed
that prevalence of depression depends on age and gender
[34,35]. Thus, DIF due to these variables might be sus-
pected. Secondly, prior studies analysing self-report
instruments for depression found DIF related to age
[36-38] and DIF related to gender [39]. Furthermore, we
considered it most important to investigate whether the
DESC can be used for both genders and all age groups
without different norms because this would imply a nota-
ble practical advantage for clinical practice. Therefore,
Item difficulty measures δi were computed for each class
of subjects (e.g., men vs. women) to be contrasted. A
two-sided t-test was then performed pair wise comparing
item difficulty measures for subject classes (a ≤ 0.01). In
accordance to the studies reporting the initial develop-
ment of the DESC [20,23] and following Linacre’s recom-
mendations to interpret these t-tests conservatively,
additionally to the significant t-test, a DIF contrast (i.e.,
DIF measure for subject class 1 minus subject class 2) of
| > .5| was considered substantial [33].
Step 2: Determination of DESC norm values and measures
of convergent and divergent validity
After determination of adherence to Rasch model
assumptions norm values were calculated separately for
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First, based on the individual raw sum scores each per-
son’sl a t e n tt r a i ts c o r eθ was calculated. Then, trait
scores θ were transformed linearly into percentiles,
z-values (mean = 0, SD = 1) and T-values (mean = 50,
SD = 10). Afterwards, correlations of both DESC forms
with the depression and the anxiety scale of the HADS
were calculated as measures for convergent and diver-
gent validity. Possible applications of these normative
data for the assessment of change in clinical diagnostics
are exemplified in the discussion section.
All analyses were conducted using WINSTEPS 3.60.1
and SPSS 17.
Results
Step 1: Rasch analysis
Separation and reliability
Item separation for DESC-I (11.15) and DESC-II (11.11)
w a sv e r yg o o da sw e l la si t e mr e l i a b i l i t y( D E S C - I=. 9 9 ;
DESC-II = .99). Person separation (DESC-I = 1.51; DESC-
II = 1.75) and person reliability (DESC-I = .69; DESC-II =
.75) failed slightly the critical values. Cronbach’s a was
high with .92 for DESC-I and .93 for DESC-II, respectively.
Rasch model fit
All items of both DESC-I and DESC-II adhered to the
infit and outfit criteria of < 1.3 indicating very good
Rasch model fit. See table 2 for details.
Unidimensionality and local independence
To evaluate unidimensionality and local independence
the residual correlation matrix was examined. A princi-
pal component factor analysis of the residuals (PCFAR)
revealed that the Rasch dimension “depression”
explained 68.5% of the variance (eigenvalue 21.8) in
D E S C - Ia n d6 9 . 3 %o ft h ev a r i a n c e( e i g e n v a l u e2 2 . 6 )i n
DESC-II. The biggest potential secondary dimension
explained 5.0% of the variance (eigenvalue 1.6) both in
DESC-I and DESC-II. This result is in line with the
assumptions of both unidimensionality and local inde-
pendence of the data, since the recommendations of
Linacre [33] are fulfilled.
Evaluation of Differential Item Functioning (DIF)
There were no signs of DIF due to age or gender for
both DESC-I and DESC-II. Thus, sum scores of both
forms of DESC may be interpreted independently from
the respondents’ age or gender.
Step 2: Determination of DESC norm values and
measures of convergent and divergent validity
Since Rasch model conformity of both forms of the
DESC could be confirmed in the present sample, norm
values were determined applying the routine outlined
above. Norms were not calculated separately for gender
or different age groups, since Rasch analysis revealed
that DESC sum-scores can be interpreted independently
of age or gender. Norm values (percentiles, Z-, and
T-scores) are presented in tables 3 and 4 together with
raw scores and the Rasch measures θ.
The population mean of DESC-I was M = 3.9 (SD =
5.4) and of DESC-II was M = 4.0 (SD = 5.6). When
applying the proposed cut-off score of 12 [20], DESC-I
would classify 10.0% of the representative sample as
being depressed, while DESC-II classifies 10.8% to be
depressed. The concordance of both classifications
according to the coefficient  for nominal data is  =
.73. The depression subscale of the HADS would classify
24.5% of the sample as depressed.
The parallel test reliability of DESC-I and -II was r =
.93 (p < .01). The correlation with the depression sub-
scale of the HADS was moderate for DESC-I (r = .61;
p < .01) as well as for DESC-II (r = .60). The correlation
with the anxiety subscale of the HADS was r = .62 for
DESC-I and r = .60 for DESC-II.
Discussion
This study aimed at validating the DESC in a represen-
tative sample of the German general population and at
Table 3 Norm values for DESC-I
raw score frequency percentage percentiles θ ZT
0 841 33.5 33.5 -5.80 -1.09 39
1 390 15.5 49.1 -4.52 -0.38 46
2 271 10.8 59.9 -3.71 0.07 51
3 199 7.9 67.8 -3.19 0.36 54
4 153 6.1 73.9 -2.78 0.59 56
5 126 5.0 78.9 -2.42 0.79 58
6 105 4.2 83.1 -2.10 0.97 60
7 66 2.6 85.7 -1.81 1.13 61
8 69 2.8 88.5 -1.53 1.29 63
9 61 2.4 90.9 -1.26 1.44 64
10 60 2.4 93.3 -1.00 1.58 66
11 59 2.4 95.7 -0.75 1.72 67
12 42 1.7 97.3 -0.51 1.86 69
13 14 .6 97.9 -0.28 1.99 70
14 11 .4 98.3 -0.06 2.11 71
15 11 .4 98.8 0.16 2.23 72
16 8 .3 99.1 0.37 2.35 73
17 6 .2 99.3 0.57 2.46 75
18 4 .2 99.5 0.78 2.58 76
19 3 .1 99.6 0.98 2.69 77
20 3 .1 99.7 1.18 2.80 78
21 2 .1 99.8 1.38 2.91 79
22 1 .0 99.8 1.59 3.03 80
23 1 .0 99.9 1.82 3.16 82
26 1 .0 99.9 2.61 3.60 86
27 1 .0 100.0 2.97 3.80 88
>/= 28 1 .0 100.0 3.45 4.07 91
Note: θ: estimated person’s latent trait score for depression; Z: mean = 0,
SD = 1; T: mean = 50, SD = 10
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and divergent validity of both forms of the instrument.
Overall, both forms of the DESC adhered to Rasch
model assumptions. We found very good Rasch model
fit according to infit and outfit statistics, strong evidence
for unidimensionality and local independence, and no
signs of differential item functioning. Keeping in mind
that the DESC’s validity in clinical samples has already
been shown [20,40], these results additionally suggest,
that the DESC appears to be a psychometrically sound
instrument for screening for depression in the general
population. Furthermore, the high parallel test reliability
could be replicated indicating that the DESC can be
applied as true parallel versions of the same inventory in
retest applications.
The fraction of the sample that was classified as
depressed when applying the proposed cut-off score of
the two DESC parallel forms roughly corresponds to the
German prevalence rates reported in the literature [see
e.g., 41]. While sound criteria for external validity are
lacking in the current study, this concordance may be
cautiously interpreted as suggesting validity. Further-
more, prior studies in patient samples indicated good
external validity of the DESC [see e.g., 20].
The reported values for convergent and divergent
validity were moderate. Anxiety and depression are
known to be substantially correlated so that moderate
positive correlations of self-report instruments for
depression with measures of anxiety are a common phe-
nomenon. Thus, the moderate positive correlation with
the anxiety subscale of the HADS is in concordance
with prior literature [42]. Furthermore, the correlation
between the depression and anxiety subscales of the
HADS itself was comparably high (r = .68) so that the
moderate positive correlation of the DESC with anxiety
does not flaw its validity.
We expected high convergent validity with the depres-
sion subscale of the HADS. However, the revealed cor-
relation was only moderate, too. In order to appraise the
significance of this result for the standing of the DESC
compared to the established self-report instruments for
depression, like the HADS [4], the Beck Depression
Inventory [BDI; 1], or the Center for Epidemiologic Stu-
dies Depression Scale [CES-D; 43], it has to be taken
into account that moderate convergent validity with
other self-report instruments for depression has been
reported for most other depression questionnaires, too.
For example, both Bonilla and colleagues [44] and
K o j i m aa n dc o l l e a g u e s[ 4 5 ]r e p o r t e dac o r r e l a t i o n
between BDI and CES-D of r = .69. Cameron and col-
leagues [46] found a correlation between the HADS and
the Patient Health Questionnaire [PHQ-9; 2] of r =. 6 8 .
Thus, the correlation between DESC and the depression
subscale of the HADS is in concordance with recent
findings from the literature. Furthermore, HADS and
DESC might emphasize different aspects of depression.
For example, in contrast to the HADS both forms of the
DESC contain an item about suicidal ideation and beha-
viour which could at least partly account for the surpris-
ing results. Moreover, DESC (2 weeks) and HADS
(1 week) refer to different timeframes and the HADS
contains items with changing polarity whereas the
DESC does not. Theses factors might add to the rela-
tively low correlation of the scales. Above, in our sample
the HADS classified more then twice as many persons
as depressed as the DESC. Since the DESC classifica-
tions roughly correspond to the prevalence of depres-
sion reported in the literature this result might be
interpreted as indicating that the HADS tends to pro-
duce “false positives” in the general population - a fact
that has already been discussed for depression screening
with the HADS in other samples [e.g., 26]. Nevertheless,
Table 4 Norm values for DESC-II
raw score frequency percentage percentiles θ ZT
0 963 38.4 38.4 -6.03 -1.02 40
1 273 10.9 49.3 -4.74 -0.36 46
2 244 9.7 59.0 -3.93 0.05 50
3 159 6.3 65.3 -3.41 0.31 53
4 129 5.1 70.5 -3.00 0.52 55
5 120 4.8 75.2 -2.66 0.70 57
6 106 4.2 79.5 -2.35 0.85 59
7 81 3.2 82.7 -2.08 0.99 60
8 58 2.3 85.0 -1.82 1.12 61
9 54 2.2 87.2 -1.58 1.25 62
10 55 2.2 89.4 -1.35 1.36 64
11 47 1.9 91.2 -1.13 1.48 65
12 37 1.5 92.7 -0.92 1.58 66
13 44 1.8 94.5 -0.71 1.69 67
14 37 1.5 95.9 -0.51 1.79 68
15 30 1.2 97.1 -0.31 1.89 69
16 17 .7 97.8 -0.11 1.99 70
17 17 .7 98.5 0.08 2.09 71
18 5 .2 98.7 0.27 2.19 72
19 6 .2 98.9 0.46 2.29 73
20 6 .2 99.2 0.65 2.38 74
21 3 .1 99.3 0.84 2.48 75
22 7 .3 99.6 1.03 2.58 76
23 2 .1 99.6 1.22 2.67 77
24 3 .1 99.8 1.41 2.77 78
25 1 .0 99.8 1.61 2.87 79
26 1 .0 99.8 1.82 2.98 80
27 2 .1 99.9 2.05 3.10 81
30 1 .0 100.0 2.86 3.51 85
>/= 31 1 .0 100.0 3.22 3.69 87
Note: θ: estimated person’s latent trait score for depression; Z: mean = 0,
SD = 1; T: mean = 50, SD = 10
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validity of the DESC to substantiate the present findings.
Possible applications of the presented normative data
The DESC was shown to be a reliable and valid instru-
ment in prior studies [20,40]. Its sum-score can be
interpreted as valid quantitative estimate of a person’s
depressive symptom burden, and it provides a sensitive
and specific cut-off score which aids in deciding
whether a depressive disorder is likely to be present.
However, the normative data presented in the current
study further facilitate the clinical utilization of the
instrument. The provided T- and Z-scores allow for
comparing DESC sumscores with the distribution of
sumscores in the general population. Thus, clinicians
may now come to a rapid binary decision about the
clinical status of a patient by applying the cut-off score.
But above, a more fine graded evaluation of the patient’s
state is possible by comparing his scores with the distri-
bution in the general population. This may be beneficial
for clinical application, particularly in repeated assess-
ments. The issue how to determine significant change
across treatment has been subject to intense and vivid
discourse in psychotherapy research in the past [see 47
for a review]. Important recommendations how to deal
with this problem have been made by e.g. Jacobson and
Truax [48]. Amongst other important suggestions, they
point out that a central aspect of the evaluation of clini-
cal significant change is the returning of the patient’s
score to the range of the mean plus one standard devia-
tion of the general population distribution. This refers
to the “cutoff point b“ as presented by the authors [see
47 for details]. With the normative data presented here,
clinicians now can follow this recommendation when
using the DESC.
Conclusions
Taken together, the present study provides further evi-
d e n c ef o rt h ep s y c h o m e t r i cq u a l i t yo ft h eD E S Ca n d
opens new opportunities for sumscore interpretation
through the presentation of normative data. The major
strengths of the instrument can be expected in retest
applications in both clinical and nonclinical samples.
We conclude that the instrument can be useful in deal-
ing with the central challenges of clinical assessment: (1)
to measure a patient’s symptom burden quantitatively,
(2) to decide, whether this measurement indicates the
presence of a depressive disorder, and (3) to judge
whether symptom burden changes in the course of
treatment.
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